Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
2 hedge funds and large institutions have $9.27K invested in Celyad Oncology SA American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 8 closing their positions.
75% less funds holding
Funds holding: 8 → 2 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
100% less capital invested
Capital invested by funds: $6.29M → $9.27K (-$6.28M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$12.9K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$6.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
Fortress Investment Group
New York
|
-$6.23M |
| 2 |
KI
Kapitalo Investimentos
Sao Paulo,
Brazil
|
-$29.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15.3K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10.6K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$3.09K |
CYAD Hedge Fund Activity: Q2 2023 in Review
2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q2 2023, worth a combined $9.27K — down 100% from $6.29M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CYAD and 2 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Baader Bank Aktiengesellschaft, opening a new position worth an estimated $12.9K. The largest seller was Fortress Investment Group, exiting entirely with an estimated $6.23M sold.
- 2 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q2 2023, down from 8 in Q1 2023.
- Funds reported $9.27K of Celyad Oncology SA American Depositary Shares stock for Q2 2023, down 100% quarter-over-quarter.
- 2 funds opened new Celyad Oncology SA American Depositary Shares positions in Q2 2023 and 8 closed out, a net change of -6 holders.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q2 2023 was Baader Bank Aktiengesellschaft, an estimated $12.9K added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q2 2023 was Fortress Investment Group, an estimated $6.23M sold.
Based on aggregated 13F filings for Q2 2023.